Related Experiment Video

Updated: Dec 6, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.8K

Combating Inflammation in Cardiovascular Disease

Anver M Sethwala1, Ian Goh1, John V Amerena1

  • 1Department of Cardiology, University Hospital Geelong, Barwon Health, Vic, Australia.

Heart, Lung & Circulation
|October 11, 2020
PubMed

Insights

Inflammation drives atherosclerosis and cardiovascular disease. Targeting the NLRP3 inflammasome pathway, monitored by high-sensitivity C-reactive protein (hs-CRP), offers a promising strategy for cardiovascular risk reduction.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Pharmacology

Background:

  • Inflammation plays a critical role in the development of atherosclerosis and cardiovascular disease (CVD).
  • Recent clinical trials like CANTOS and COLCOT highlight the benefits of anti-inflammatory therapies in CVD risk reduction.
  • The Nod-like receptor protein 3 (NLRP3) inflammasome pathway is a key target for managing inflammatory processes in CVD.

Purpose of the Study:

  • To review the role of inflammation in cardiovascular disease pathogenesis.
  • To discuss the clinical utility of high-sensitivity C-reactive protein (hs-CRP) as an inflammatory biomarker.
  • To explore emerging anti-inflammatory treatments for cardiovascular risk management.

Main Methods:

  • Literature review of key clinical trials (e.g., CANTOS, COLCOT) and relevant research.
  • Analysis of the NLRP3 inflammasome pathway and its downstream mediators (IL-1, IL-18, IL-6).
  • Evaluation of hs-CRP as a biomarker for monitoring inflammatory status and treatment response.

Main Results:

  • Targeting the NLRP3 inflammasome-cytokine pathway demonstrates significant cardiovascular risk reduction.
  • Hs-CRP serves as a valuable downstream biomarker for assessing inflammation and guiding therapeutic interventions.
  • Anti-inflammatory strategies represent an evolving approach to managing cardiovascular risk.

Conclusions:

  • The link between inflammation and atherosclerosis is well-established, with specific pathways offering therapeutic targets.
  • Hs-CRP is a clinically useful marker for inflammation in cardiovascular disease.
  • Further research on the cost-effectiveness and long-term safety of novel anti-inflammatory agents is warranted.
Keywords:
Cardiovascular diseaseHigh-sensitivity C-reactive proteinInflammation

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
222
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
155
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.2K
Inflammation01:38

Inflammation

Overview
60.3K